The International Trade Commission has requested an additional week to decide whether it will commence an investigation requested by pharmaceutical company Amarin concerning certain high concentrate omega-3 fish oil ingredients.
California-based supplement maker Custompax must stop selling products until it comes to compliance with the Food and Drug Administration (FDA)’s dietary supplement manufacturing regulations, according to a press release by the federal agency.
A combination of partially hydrolysed protein infant formula and specific prebiotic oligosaccharides leads to changes in the gut microbiota of infants at high risk of allergy, creating a microbiome that is closer to that of breastfed infants and which...
The US Food and Drug Administration has sent a letter to the International Trade Commission asking that agency not to hear a complaint in which the fish oil drug maker Amarin is seeking to prevent the import of some omega-3 dietary supplements.
Increasing scrutiny on the supply end of the dietary supplement business put the American Herbal Products Association in a position to contribute to the further legitimization of the dietary supplement industry, said the organization’s founder.
FDA’s undertaking to create a master list of ‘old dietary ingredients’ that could be sold legally in dietary supplements without first going through the new dietary ingredient notification process likely will fall flat, despite the agency’s best intentions,...
NPA's Dr Daniel Fabricant recaps state of industry at SupplySide West 2017
From finalizing an NDI list to making dietary supplements eligible in welfare programs, Dr Daniel Fabricant of the National Products Association shared his take on the state of the dietary supplements industry.